Date published: 2025-11-22

1-800-457-3801

SCBT Portrait Logo
Seach Input

ENX-2 Inhibitors

ENX-2 inhibitors represent a class of chemical compounds specifically designed to target and modulate the activity of the enzyme ENX-2, also known as Eukaryotic Nucleosome-Remodeling Factor 2. ENX-2 is a crucial component in chromatin remodeling, playing a pivotal role in the dynamic regulation of gene expression and chromosomal architecture. This class of inhibitors is characterized by their ability to selectively bind to the active site of ENX-2, thereby hindering its catalytic function. The inhibition of ENX-2 is of particular interest in the field of molecular biology and biochemistry, as it allows researchers to gain insights into the intricate mechanisms governing chromatin dynamics and epigenetic regulation.

ENX-2 inhibitors often feature a pharmacophore tailored to interact with the catalytic pocket of the enzyme, disrupting its enzymatic activity without interfering with other cellular processes. The design of these inhibitors is guided by a deep understanding of the three-dimensional structure of ENX-2 and the identification of key residues involved in its substrate recognition and catalysis. By selectively modulating ENX-2 activity, these inhibitors enable the manipulation of chromatin structure, offering a powerful tool for studying gene expression patterns and unraveling the complex interplay between chromatin remodeling and various cellular processes

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

GSK126

1346574-57-9sc-490133
sc-490133A
sc-490133B
1 mg
5 mg
10 mg
$90.00
$238.00
$300.00
(0)

A selective inhibitor of EZH2, which can also reduce EZH1 activity due to the structural and functional similarities between EZH1 and EZH2.

UNC1999

1431612-23-5sc-475314
5 mg
$142.00
1
(0)

A dual inhibitor of EZH1 and EZH2, it binds to the SET domain of these enzymes, preventing their histone methyltransferase activity.

EPZ6438

1403254-99-8sc-507456
1 mg
$66.00
(0)

Primarily an EZH2 inhibitor, it can inhibit EZH1 to a lesser extent, leading to reduced methylation of histone H3 on lysine 27 (H3K27).